+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aptamers Market Report by Type, Application, and Region 2024-2032

  • PDF Icon

    Report

  • 147 Pages
  • August 2024
  • Region: Global
  • IMARC Group
  • ID: 5901314
The global aptamers market size reached US$ 2.6 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 18.3% during 2023-2032.

Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.

Global Aptamers Market Trends:

The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers.

Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global aptamers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and application.

Breakup by Type:

  • Nucleic Acid
  • Peptide

Breakup by Application:

  • Diagnostics
  • Therapeutics
  • Research and Developments
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.

Key Questions Answered in This Report:

  • How has the global aptamers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global aptamers market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global aptamers market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aptamers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Nucleic Acid
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Peptide
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Diagnostics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Therapeutics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Research and Developments
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Aptagen LLC
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Aptamer Group
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Aptamer Sciences Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Aptus Biotech S.L.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Base Pair Biotechnologies Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 IBA GmbH
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 NeoVentures Biotechnology Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 NOXXON Pharma
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 SomaLogic Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 TriLink BioTechnologies LLC
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.12 Vivonics Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Aptamers Market: Major Drivers and Challenges
Figure 2: Global: Aptamers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Aptamers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Aptamers Market: Breakup by Type (in %), 2023
Figure 5: Global: Aptamers Market: Breakup by Application (in %), 2023
Figure 6: Global: Aptamers Market: Breakup by Region (in %), 2023
Figure 7: Global: Aptamers (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Aptamers (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Aptamers (Peptide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Aptamers (Peptide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Aptamers (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Aptamers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Aptamers (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Aptamers (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Aptamers (Research and Developments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Aptamers (Research and Developments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Aptamers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Aptamers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: North America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: North America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: United States: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: United States: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Canada: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Canada: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Asia-Pacific: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Asia-Pacific: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: China: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: China: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Japan: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Japan: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: India: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: India: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: South Korea: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: South Korea: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Australia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Australia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Indonesia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Indonesia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Europe: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Europe: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Germany: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Germany: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: France: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: France: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: United Kingdom: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: United Kingdom: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Italy: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Italy: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Spain: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Spain: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Russia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Russia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Latin America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Latin America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Brazil: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Brazil: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Mexico: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Mexico: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Middle East and Africa: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Middle East and Africa: Aptamers Market: Breakup by Country (in %), 2023
Figure 67: Middle East and Africa: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Global: Aptamers Industry: SWOT Analysis
Figure 69: Global: Aptamers Industry: Value Chain Analysis
Figure 70: Global: Aptamers Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Aptamers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Aptamers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Aptamers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Aptamers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Aptamers Market: Competitive Structure
Table 6: Global: Aptamers Market: Key Players

Companies Mentioned

  • Aptagen LLC
  • Aptamer Group
  • Aptamer Sciences Inc.
  • Aptus Biotech S.L.
  • Base Pair Biotechnologies Inc.
  • IBA GmbH
  • Kaneka Eurogentec S.A. (Kaneka Corporation)
  • NeoVentures Biotechnology Inc.
  • NOXXON Pharma
  • SomaLogic Inc.
  • TriLink BioTechnologies LLC
  • Vivonics Inc.

Methodology

Loading
LOADING...

Table Information